Vertex (VRTX) CMO Carmen Bozic Sells 4,062 Shares

What Happened

• Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), sold 4,062 shares in an open-market transaction on June 15, 2026. The shares were sold at $450.00 per share for total proceeds of $1,827,900. This was a sale (not a purchase); sales by insiders can be routine and may be pre-scheduled under trading plans.

Key Details

• Transaction date and price: 2026-06-15 — 4,062 shares sold at $450.00 per share.
• Total value: $1,827,900.
• Footnote: Transaction was made pursuant to Dr. Bozic’s company-approved Rule 10b5-1 trading plan entered into on 11/20/2025.
• Filing timeliness: Form 4 was filed on 2026-06-17 (within the standard two-business-day reporting window), so the filing appears timely.
• Shares owned after transaction: Not specified in the excerpt provided.

Context

• The sale was executed under a 10b5-1 plan, which allows insiders to sell pre-scheduled amounts and dates; such trades are often routine and do not necessarily indicate a change in the insider’s view of the company.